Cargando…

Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma

AIMS: To guide clinicians in selecting treatment options for esophageal squamous cell carcinoma (ESCC) patients, reliable markers predictive of clinical outcome are desirable. This study analyzed the correlation of cyclophilin A (CypA) and matrix metalloproteinase 9 (MMP9) in ESCC and their relation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yi, Guo, Hui, Dong, Danfeng, Wu, Huili, Li, Enxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878405/ https://www.ncbi.nlm.nih.gov/pubmed/24351116 http://dx.doi.org/10.1186/1746-1596-8-207

Ejemplares similares

Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma
por: Yu, Xiang-Yang, et al.
Publicado: (2022)

Matrix Metalloproteinase 1, 3, and 9 Polymorphisms and Esophageal Squamous Cell Carcinoma Risk
por: Guan, Xuan, et al.
Publicado: (2014)

Increased matrix metalloproteinase activation in esophageal squamous cell carcinoma
por: Mukherjee, Sumana, et al.
Publicado: (2010)

Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma
por: Mishev, Georgi, et al.
Publicado: (2014)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Fluctuating Roles of Matrix Metalloproteinase-9 in Oral Squamous Cell Carcinoma
por: Vilen, Suvi-Tuuli, et al.
Publicado: (2013)

Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis
por: Andisheh-Tadbir, Azadeh, et al.
Publicado: (2016)

Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis
por: Ye, Ziqi, et al.
Publicado: (2020)

Gene polymorphisms of cyclin‐dependent kinase inhibitor and matrix metalloproteinase‐9 in Sudanese patients with esophageal squamous cell carcinoma
por: Eltayeb, Majdolin Mohammed, et al.
Publicado: (2022)

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma
por: Bai, Xue, et al.
Publicado: (2017)

Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma
por: Liu, Wan-li, et al.
Publicado: (2010)

Plasma matrix metalloproteinase 1 improves the detection and survival prediction of esophageal squamous cell carcinoma
por: Chen, Yu-Kuei, et al.
Publicado: (2016)

Expression levels of matrix metalloproteinase-9 in human gastric carcinoma
por: CHEN, SU-ZUAN, et al.
Publicado: (2015)

Little genomic support for Cyclophilin A-matrix metalloproteinase-9 pathway as a therapeutic target for cognitive impairment in APOE4 carriers
por: Anderson, Emma L., et al.
Publicado: (2022)

Expression of matrix metalloproteinase-9 in histological grades of oral squamous cell carcinoma: An immunohistochemical study
por: Patil, Rekha, et al.
Publicado: (2021)

Role of Matrix Metalloproteinase 9 in Predicting Lymph Node Metastases in Oral Squamous Cell Carcinoma
por: Chakraborty, Satadruti, et al.
Publicado: (2023)

Expression of Matrix Metalloproteinase-2/9 and Tissue Inhibitor of Metalloproteinase-1/2 as Predictive Factors in Oropharyngeal Squamous Cell Carcinoma
por: Burduk, Pawel-Krzysztof, et al.
Publicado: (2019)

A Sensitive and Selective Method for Determination of Aesculin in Cortex Fraxini by Liquid Chromatography Quadrupole Time-of-Flight Tandem Mass Spectrometry and Application in Pharmacokinetic Study
por: Li, Yi, et al.
Publicado: (2013)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Plasma Matrix Metalloproteinase-1 as a Prognostic Biomarker in Oral Cavity Squamous Cell Carcinoma
por: Tsai, Tsung-You, et al.
Publicado: (2022)

Pan-cancer analysis of the prognostic and immunological role of matrix metalloproteinase 9
por: Zhang, Jie, et al.
Publicado: (2023)

Prognostic role of matrix metalloproteinase 9 in early breast cancer
por: Kalavska, Katarina, et al.
Publicado: (2021)

Expression of Matrix Metalloproteinase-21 in Oral Squamous Cell Carcinoma
por: Baskaran, Adhithya, et al.
Publicado: (2023)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Evaluation of matrix metalloproteinase 9 gene expression in oral squamous cell carcinoma and its clinicopathological correlation
por: Umashankar, Krishnapriya, et al.
Publicado: (2021)

Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2021)

Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study
por: Wang, Miaomiao, et al.
Publicado: (2014)

Prognostic relevance of Centromere protein H expression in esophageal carcinoma
por: Guo, Xian-Zhi, et al.
Publicado: (2008)

Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma
por: Wang, Jian-Hua, et al.
Publicado: (2017)

Association of Matrix Metalloproteinase-7 (-181A>G) Polymorphism with Risk of Esophageal Squamous Cell Carcinoma in Kashmir Valley
por: Malik, Manzoor A., et al.
Publicado: (2011)

Matrix metalloproteinase‐14 (MMP‐14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation
por: Chen, Nanzheng, et al.
Publicado: (2020)

Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis
por: Tsukamoto, Shuichi, et al.
Publicado: (2023)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020)

Correlation Between the Expression of Matrix Metalloproteinase-9, Matrix Metalloproteinase-13, Tissue Inhibitor of Metalloproteinases-1, p16 and Differentiation of Head and Neck Squamous Cell Carcinoma: A Prospective Observational Study
por: Soni, Kapil, et al.
Publicado: (2021)

Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, and Changes in Alveolar Septa in Patients with Chronic Obstructive Pulmonary Disease
por: Zhang, Yongxiang, et al.
Publicado: (2020)

Evaluation of Serum Levels of Matrix MetalloProteinase-9 (MMP-9) in Oral Squamous Cell Carcinoma and Its Clinicopathological Correlation
por: Benitha, Georgia, et al.
Publicado: (2023)

The influence of matrix metalloproteinase-2, -9, and -12 promoter polymorphisms on Iranian patients with oesophageal squamous cell carcinoma
por: Eftekhary, Haniehsadat, et al.
Publicado: (2015)

Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women
por: Youssef, Nermeen Salah, et al.
Publicado: (2014)

Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
por: CHEN, SHAO-JUN, et al.
Publicado: (2016)

ACADL Functions as a Tumor Suppressor in Hepatocellular Carcinoma Metastasis by Inhibiting Matrix Metalloproteinase 14
por: Guo, Danfeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gk9vtvcenrcr88kuvhbfjg9qp4